Bessemer Group Inc Tango Therapeutics, Inc. Transaction History
Bessemer Group Inc
- $60.7 Billion
- Q3 2024
A detailed history of Bessemer Group Inc transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 708,384 shares of TNGX stock, worth $2.06 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
708,384
Previous 708,384
-0.0%
Holding current value
$2.06 Million
Previous $6.08 Million
10.25%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
126Shares Held
91.8MCall Options Held
3.1KPut Options Held
1.5K-
Trv Gp Iv, LLC Boston, MA16.9MShares$49.1 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$38.8 Million4.45% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$23.9 Million3.35% of portfolio
-
Nextech Invest Ag5.53MShares$16.1 Million6.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.02MShares$14.6 Million0.02% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $256M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...